Corvex, Inc. Annual Report - How They Did This Year

I’m writing this guide to help you understand how Corvex, Inc. performed this year. My goal is to cut through the corporate jargon and explain what is actually happening with the business so you can decide if it belongs in your portfolio.

1. What does this company do?

Corvex, Inc. (formerly Movano Inc.) has undergone a massive transformation. As of early 2026, they operate in two distinct areas:

• AI Cloud Computing: They provide infrastructure—high-powered GPU clusters—designed for training AI models. Their 45,000-square-foot facility in Delaware provides 15 megawatts of power, specifically configured for the liquid cooling that modern AI hardware requires.
• Healthcare: They develop wearable health trackers, including the "Wellness Ring" and "Medical Ring," which use sensors to monitor blood pressure and glucose trends.

2. The Big Pivot

In May 2025, the company merged with Corvex OpCo in a $420 million all-stock deal. This changed the business fundamentally. They are currently positioning the healthcare business for sale to focus exclusively on high-margin AI infrastructure.

The healthcare division is now in "reduced capacity" mode, with research spending cut by 65% compared to last year. Additionally, sales of the Wellness Ring are currently paused due to a trademark lawsuit, which carries a potential liability of up to $12 million in damages.

3. The AI Strategy: Betting on the "AI Factory"

The company is betting its future on the AI boom by acting as a specialized provider of computing power:

• The Hardware: They operate a high-security data center in Delaware equipped with 1,200 NVIDIA H200 units and 400 B200 "Blackwell" chips. They invested $88 million in this hardware last year.
• The Competitive Edge: Rather than competing directly with hyperscalers like Amazon or Google, they operate as a "boutique" provider. Their custom software reduces training time by 22% compared to standard cloud environments, allowing them to charge a premium of $4.50 per GPU-hour.
• The Risks: Success depends on their ability to stay at the cutting edge of hardware. Because they compete against companies with massive capital resources, they must raise an additional $150 million over the next 18 months to remain competitive.

4. Financial Health & Risks

The company is currently in a "growth at all costs" phase, reporting a $54 million loss on $12.4 million in revenue this year.

• Regulatory Hurdles: They must navigate the EU AI Act and data privacy laws, while simultaneously maintaining FDA clearance for their medical sensors.
• Operational Risks: The sales pause on the Wellness Ring resulted in a $4.2 million write-down in inventory value. With a monthly cash burn of $3.8 million, the company has approximately nine months of runway before they will need to secure additional financing or debt.
• Intellectual Property: While they hold 30 patents for their healthcare technology, their long-term value is tied to their proprietary AI software, which is the primary driver of their performance advantage.

5. The Bottom Line

Corvex is a high-risk, high-reward play. The healthcare business is a legacy asset slated for divestiture, while the AI business is a capital-intensive startup. If you are considering an investment, watch for two key milestones: the successful resolution of the trademark lawsuit and the company's ability to raise the $150 million required for their AI infrastructure expansion.